Related references
Note: Only part of the references are listed.Genetically Engineered Mouse Models of Brain Cancer and the Promise of Preclinical Testing
Jason T. Huse et al.
BRAIN PATHOLOGY (2009)
The Rheb-mTOR Pathway Is Upregulated in Reactive Astrocytes of the Injured Spinal Cord
Simone Codeluppi et al.
JOURNAL OF NEUROSCIENCE (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
Kathleen R. Lamborn et al.
NEURO-ONCOLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Constitutive activation of Raf-1 induces glioma formation in mice
Yelena Lyustikman et al.
NEOPLASIA (2008)
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
Rameen Beroukhim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities
Elizabeth A. Maher et al.
CANCER RESEARCH (2006)
Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain
Jeffrey C. Lee et al.
PLOS MEDICINE (2006)
Mouse models of brain tumors and their applications in preclinical trials
Elena I. Fomchenko et al.
CLINICAL CANCER RESEARCH (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Distinct transcription profiles of primary and secondary glioblastoma subgroups
CL Tso et al.
CANCER RESEARCH (2006)
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: Tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01
AB Lassman et al.
CLINICAL CANCER RESEARCH (2005)
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme
Y Liang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats
CK Dai et al.
NEOPLASIA (2005)
Postgenomic global analysis of translational control induced by oncogenic signaling
VK Rajasekhar et al.
ONCOGENE (2004)
Gene expression profiling of gliomas strongly predicts survival
WA Freije et al.
CANCER RESEARCH (2004)
Circular binary segmentation for the analysis of array-based DNA copy number data
AB Olshen et al.
BIOSTATISTICS (2004)
Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to Polysomes
VK Rajasekhar et al.
MOLECULAR CELL (2003)
Identification of molecular subtypes of glioblastoma by gene expression profiling
PS Mischel et al.
ONCOGENE (2003)
Malignant glioma: genetics and biology of a grave matter
EA Maher et al.
GENES & DEVELOPMENT (2001)
Share Paper
